Arcellx announces upsizing and pricing of follow-on public offering

-- public offering of 7,000,000 shares of common stock for gross proceeds of $112 million -- redwood city, calif. , june 15, 2022 /prnewswire/ -- arcellx, inc. (nasdaq: aclx), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the pricing of an upsized underwritten follow-on offering of 7,000,000 shares of common stock at a price to the public of $16.00 per share.
ACLX Ratings Summary
ACLX Quant Ranking